SSI INVESTMENT MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,527,733
-32.9%
6,877,000
-12.0%
0.45%
-21.8%
Q2 2023$8,240,172
-15.4%
7,818,000
-1.5%
0.58%
-15.5%
Q1 2023$9,735,966
+7.8%
7,938,000
-19.8%
0.68%
+19.4%
Q4 2022$9,035,048
-16.0%
9,896,000
-0.1%
0.57%
-20.6%
Q3 2022$10,755,000
+108.6%
9,910,000
+120.9%
0.72%
+132.2%
Q3 2021$5,155,000
-1.5%
4,487,0000.0%0.31%
-8.0%
Q2 2021$5,231,000
+9.0%
4,487,000
+4.7%
0.34%
-2.3%
Q1 2021$4,800,0004,287,0000.35%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 20,087$23,535,0002.18%
ZAZOVE ASSOCIATES LLC 15,910,000$18,551,0001.66%
SSI INVESTMENT MANAGEMENT LLC 4,487,000$5,231,0000.34%
DeepCurrents Investment Group LLC 4,918,000$5,752,0000.17%
KORNITZER CAPITAL MANAGEMENT INC /KS 3,000,000$3,500,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 12,500,000$14,646,0000.03%
Citadel Advisors 104,329,000$122,081,0000.03%
LAZARD ASSET MANAGEMENT LLC 20,000,000$23,433,0000.03%
WOLVERINE ASSET MANAGEMENT LLC 2,918,000$3,416,0000.03%
FRANKLIN RESOURCES INC 48,000,000$56,240,0000.02%
View complete list of REVANCE THERAPEUTICS INC shareholders